miR-409-3p Regulates IFNG and p16 Signaling in the Human Blood of Aging-Related Hearing Loss

• Published in: Cells (Basel, Switzerland) Switzerland), 2024-09, Vol.13 (18), p.1595
• Main Authors: Jung, Junseo, Lee, Jeongmin, Kang, Hyunsook, Park, Kyeongjin, Kim, Young Sun, Ha, Jungho, So, Seongjun, Sung, Siung, Yun, Jeong Hyeon, Jang, Jeong Hun, Choi, Seong Jun, Choung, Yun-Hoon
• Format: Article
• Language: English
• Subjects: Age; Aged; Aging; Aging - genetics; Analysis; Apoptosis; Apoptosis - genetics; Auditory system; Biological response modifiers; Blood; Cell death; Chromosome 3; Cyclin-Dependent Kinase Inhibitor p16 - genetics; Cyclin-Dependent Kinase Inhibitor p16 - metabolism; Down-regulation; Ears & hearing; Ethylenediaminetetraacetic acid; Female; Ferroptosis; Gene expression; Gene Expression Regulation; Gene regulation; Genes; Genetic aspects; Genome-wide association studies; Genomes; Genomics; Hearing loss; Hearing Loss - blood; Hearing Loss - genetics; Humans; IFNG; Inflammation; Interferon; Interferon-gamma - metabolism; Investigations; Male; Messenger RNA; MicroRNA; MicroRNAs; MicroRNAs - blood; MicroRNAs - genetics; MicroRNAs - metabolism; Middle Aged; miRNA; Molecular modelling; mRNA; P16; Population studies; Presbycusis - genetics; Reporter gene; Senescence; Signal Transduction - genetics; γ-Interferon
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells13181595

Presbycusis, also referred to as age-related hearing loss (ARHL), is a multifaceted condition caused by the natural aging process affecting the auditory system. Genome-wide association studies (GWAS) in human populations can identify potential genes linked to ARHL. Despite this, our knowledge of the biochemical and molecular mechanisms behind the condition remains incomplete. This study aims to evaluate a potential protective tool for ARHL treatment by comparing human blood-based target gene-miRNA associations regulated in ARHL. To identify promising target genes for ARHL, we utilized an mRNA assay. To determine the role of miRNA in ARHL, we investigated the expression profile of miRNA in whole blood in ARHL patients with real-time polymerase chain reaction (RT-qPCR). A reporter gene assay was performed to confirm the regulation of candidate genes by microRNA. Through RT-qPCR validation analysis, we finally confirmed the relationship between ARHL and the role of the interferon-gamma (IFNG) gene. This gene can be regarded as an age-related gene. Through gene ontology (GO) analysis, it has been found that these genes are enriched in pathways related to apoptosis. Among them, IFNG induces an inflammatory response, apoptotic cell death, and cellular senescence. We found that miR-409-3p downregulates the expression of the IFNG in vitro. In addition, the downregulation of the IFNG by miRNA 409-3p promoted cell apoptosis and suppressed proliferation. In conclusion, our study produced gene signatures and associated microRNA regulation that could be a protective key for ARHL patients. IFNG genes and miR-409-3p should be investigated for their usefulness as a new biomarker for treatment modality.